171663-13-1

Basic information

• Product Name: TERT-BUTYL 3-BROMOBENZYLCARBAMATE
• Synonyms: (3-BROMO-BENZYL)-CARBAMIC ACID TERT-BUTYL ESTER;1-(Boc-aMinoMethyl)-3-broMobenzene;N-Boc-3-broMobenzylaMine;Carbamic acid, N-[(3-bromophenyl)methyl]-, 1,1-dimethylethyl ester;N-[(3-Bromophenyl)Methyl]-Carbamic Acid 1,1-Dimethylethyl Ester;tert-butyl N-[(3-bromophenyl)methyl]carbamate;TERT-BUTYL 3-BROMOBENZYLCARBAMATE
• CAS NO: 171663-13-1
• Molecular Formula: C₁₂H₁₆BrNO₂
• Molecular Weight: 286.16494
• Product Categories: amine|alkyl bromide| carboxylic ester
• Mol File: 171663-13-1.mol
• Article Data: 38

Chemical Properties

• Boiling Point: 370.3 °C at 760 mmHg
• Flash Point: 177.8 °C
• Appearance: /
• Density: 1.319 g/cm³
• Storage Temp.: 2-8°C
• CAS DataBase Reference: TERT-BUTYL 3-BROMOBENZYLCARBAMATE(CAS DataBase Reference)
• NIST Chemistry Reference: TERT-BUTYL 3-BROMOBENZYLCARBAMATE(171663-13-1)
• EPA Substance Registry System: TERT-BUTYL 3-BROMOBENZYLCARBAMATE(171663-13-1)

Safety Data

• Hazard Codes: Xn
• Statements: 22
• Hazardous Substances Data: 171663-13-1(Hazardous Substances Data)

Usage

General Description

Tert-butyl 3-bromobenzylcarbamate is a chemical compound with the formula C12H16BrNO2. It is a protective agent for use in peptide synthesis, and it is commonly used as a building block in the production of pharmaceuticals and agrochemicals. TERT-BUTYL 3-BROMOBENZYLCARBAMATE is a clear liquid with a molecular weight of 276.16 g/mol and a boiling point of 255°C. Tert-butyl 3-bromobenzylcarbamate is known for its ability to protect specific functional groups during chemical reactions, making it an important tool for organic synthesis. Additionally, it is considered to be relatively stable and safe for handling in a laboratory setting.

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 39959-54-1 3-bromobenzylamine hydrochloride 
• 10269-01-9 3-bromobenzylamine 
• 183735-18-4 2-(3-bromobenzyl)isoindoline-1,3-dione 
• 823-78-9 meta-bromobenzyl bromide 
• 1228693-08-0 C₂₃H₂₁BrF₁₇NO₃ 

Downstream Products

• 603126-93-8 2-benzenesulfonylamino-3-({5-[3-(tert-butoxycarbonylamino-methyl)-phenyl]-thiophene-2-carbonyl}-amino)-propionic acid tert-butyl ester 
• 170853-04-0 t-butyl N-(3-formylbenzyl)carbamate 
• 67344-77-8 1-(3-bromophenyl)-N-methylmethanamine 
• 1257310-89-6 [3-(tert-butoxycarbonylaminomethyl)phenyl]carbamic acid 2-trimethylsilanylethyl ester 
• 1616590-15-8 (4,4-dimethyl-3,4-dihydrocarbostyril)-6-carboxylic acid (E)-3-[2-(hydroxycarbamoyl)vinyl]benzylamide 
• 1616590-17-0 (4,4-dimethyl-3,4-dihydrocarbostyril)-7-carboxylic acid (E)-3-[2-(hydroxycarbamoyl)vinyl]benzylamide 
• 1616590-39-6 C₂₄H₂₆N₂O₄ 
• 1616590-40-9 C₂₄H₂₆N₂O₄ 
• 1333145-02-0 4-chloro-N-(3-(((2-hydroxy-3,4-dioxocyclobut-1-en-1-yl)amino)methyl)phenethyl)benzenesulfonamide 
• 1333145-14-4 4-chloro-N-(3-(((2-ethoxy-3,4-dioxocyclobut-1-en-1-yl)amino)methyl)phenethyl)benzenesulfonamide 
• 1333145-13-3 (3-(2-(4-chlorophenylsulfonamido)ethyl)phenyl)methanaminium 2,2,2-trifluoroacetate 
• 1333145-11-1 tert-butyl 3-(2-(4-chlorophenylsulfonamido)ethyl)benzylcarbamate 
• 1333145-10-0 tert-butyl 3-(3-amino-3-oxopropyl)benzylcarbamate 
• 1333145-09-7 (E)-tert-butyl 3-(3-amino-3-oxoprop-1-en-1-yl)benzylcarbamate 

Relevant articles and documents

COMPOUNDS AND USES THEREOF

The present disclosure features compounds useful for the treatment of BAF complex-related disorders.

Structure-Based Discovery of Potent CARM1 Inhibitors for Solid Tumor and Cancer Immunology Therapy

CARM1 is a protein arginine methyltransferase and acts as a transcriptional coactivator regulating multiple biological processes. Aberrant expression of CARM1 has been related to the progression of multiple types of cancers, and therefore CARM1 was consid

COUMARIN-LIKE CYCLIC COMPOUND AS MEK INHIBITOR AND USE THEREOF

Disclosed are a class of coumarin-like cyclic compounds as MEK inhibitors and pharmaceutical compositions comprising the compounds, and the use of same in the preparation of a drug for treating MEK-related diseases. Particularly disclosed are compounds as shown in formula (I) and pharmaceutically acceptable salts thereof or tautomers thereof.